1. Home
  2. VCIG vs QNRX Comparison

VCIG vs QNRX Comparison

Compare VCIG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • QNRX
  • Stock Information
  • Founded
  • VCIG 2013
  • QNRX 2018
  • Country
  • VCIG Malaysia
  • QNRX United States
  • Employees
  • VCIG N/A
  • QNRX N/A
  • Industry
  • VCIG Diversified Commercial Services
  • QNRX Medical/Dental Instruments
  • Sector
  • VCIG Consumer Discretionary
  • QNRX Health Care
  • Exchange
  • VCIG Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • VCIG 23.8M
  • QNRX 4.8M
  • IPO Year
  • VCIG 2023
  • QNRX N/A
  • Fundamental
  • Price
  • VCIG $1.00
  • QNRX $0.31
  • Analyst Decision
  • VCIG
  • QNRX Strong Buy
  • Analyst Count
  • VCIG 0
  • QNRX 1
  • Target Price
  • VCIG N/A
  • QNRX $4.00
  • AVG Volume (30 Days)
  • VCIG 3.6M
  • QNRX 4.1M
  • Earning Date
  • VCIG 02-11-2025
  • QNRX 03-12-2025
  • Dividend Yield
  • VCIG 49.00%
  • QNRX N/A
  • EPS Growth
  • VCIG N/A
  • QNRX N/A
  • EPS
  • VCIG 7.82
  • QNRX N/A
  • Revenue
  • VCIG $23,548,256.00
  • QNRX N/A
  • Revenue This Year
  • VCIG N/A
  • QNRX N/A
  • Revenue Next Year
  • VCIG N/A
  • QNRX N/A
  • P/E Ratio
  • VCIG $0.13
  • QNRX N/A
  • Revenue Growth
  • VCIG 89.38
  • QNRX N/A
  • 52 Week Low
  • VCIG $0.95
  • QNRX $0.28
  • 52 Week High
  • VCIG $103.39
  • QNRX $6.18
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 35.67
  • QNRX 31.40
  • Support Level
  • VCIG $0.95
  • QNRX $0.28
  • Resistance Level
  • VCIG $1.15
  • QNRX $0.38
  • Average True Range (ATR)
  • VCIG 0.21
  • QNRX 0.07
  • MACD
  • VCIG -0.01
  • QNRX -0.02
  • Stochastic Oscillator
  • VCIG 6.67
  • QNRX 6.12

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: